Navigation Links
Stem Cell Technologies: World Market Outlook 2011-2021

NEW YORK, July 4, 2011 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Stem Cell Technologies: World Market Outlook 2011-2021

How will the stem cells market develop this decade? Our new report shows you that emerging industry and market's revenue potential from 2011 to 2021.

This report covers stem cells in therapeutic applications: technologies, products and services. You will assess events, opportunities and activities shaping that industry. We aim to save you time and aid your decisions through our research, analysis and discussions.

Our new study shows you revenue prospects for stem cells at total world, submarket and product levels to 2021. What activities will expand that market from 2011 to 2021? Our work helps you to understand the stem cells industry and market. 

When will significant numbers of stem cell therapies be launched? Which disease areas hold the greatest potential for stem cell therapies? We show you which markets will provide the best opportunities for research, product development and business from 2011 onwards.

What are the most crucial drivers and restraints in the development of stem cell therapies? How significant are other uses for stem cells, beyond therapy? Our report provides data and answers you need. 

We help you to assess the stem cell industry and market's strengths, weaknesses, trends and revenue opportunities to 2021. You will see where stem cell technologies are heading. 

Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.

Industry and market analysis to help your work - so you won't be left behind

Our report gives you revenue forecasts, growth rates and market shares. We also provide a SWOT/STEP review and analysis of companies, technologies and regulations, as well as opinions from our survey. 

We include 66 tables and charts and a research interview (shown in the accompanying lists). In particular, we cover research and applications involving pluripotent and multipotent stem cells for human use.

Stem Cell Technologies: World Market Outlook 2011-2021 shows you revenue trends, opportunities and challenges

Our report gives you the following advantages:

  • You will receive hard data for the stem cells industry and market - especially our revenue forecasts to 2021
  • You will discover revenue predictions for the overall market from 2011 to 2021
  • You will receive market forecasts for the main subsectors - stem cell therapies, stem cell services, cord blood banking and bone marrow transplants
  • You will discover revenue prospects to 2021 for the leading stem cell product
  • You will find out which disease areas are receiving the most attention from researchers and how soon treatments can be launched
  • You will receive analysis of the uses of stem cells and discussion of the commercial prospects for their use beyond therapy
  • You will review stem cell regulations, research and related activities in the US, Japan, Germany, France,Spain, the UK, Italy, China, India, Israel and South Korea
  • You will identify the leading companies in stem cell therapies, stem cell services and cord blood banking - we discuss the activities of over 40 companies there
  • You will investigate competition and opportunities influencing the industry and market
  • You will see what will stimulate and restrain the industry and market from 2011
  • You will analyse opportunities and challenges for established companies and those seeking to enter the stem cells market from 2011
  • You will review the technologies in development, assessing stem cell R&D potential
  • You will view opinion from our industry survey.

That mix of quantitative and qualitative market analysis sets our report apart. Our analysis helps you to stay ahead in commercial knowledge for stem cell technologies.

Order our report now to gain industry and market information you need 

Our report can benefit everybody interested in products, research, services and market analysis for stem cell technologies. We give predictions and answers you need. Don't miss out - please order our report now.

Visiongain is a trading partner with the US Federal Government

CCR Ref number: KD4R6

Table of Contents

1. Executive Summary

1.1 Overview of Findings

1.2 Chapter Breakdown

1.3 Research and Analysis Methods

1.3.1 Speculative Aspects of Assessing the Stem Cell Field

2. Introduction to Stem Cell Technologies

2.1 What Are Stem Cells?

2.2 How Are Stem Cells Classified?

2.2.1 Totipotency

2.2.2 Pluripotency

2.2.3 Multipotency

2.2.4 Oligopotency

2.2.5 Unipotency

2.3 Where Do Stem Cells Come From?

2.3.1 Embryonic Stem Cells Abortion Debates, IVF and Embryonic Stem Cells Harvesting Human Eggs

2.3.2 Adult Stem Cells

2.3.3 Umbilical Cord Blood Stem Cells

3. The Global Stem Cells Market 2011-2021

3.1 Defining the Stem Cells Market

3.2 Growth in the Stem Cells Market 2011-2021

3.3 Stem Cell Therapies

3.3.1 Stem Cell Therapies Market Forecast 2011-2021

3.3.2 Stem Cells and Bone Regeneration Osteocel Plus (NuVasive) Osteocel Plus Sales Forecast 2011-2021 Other Orthopaedic Stem Cell Products

3.3.3 Stem Cells and Regenerative Medicine

3.3.4 Stem Cell Cosmetics

3.3.5 Unregulated Stem Cell Therapies

3.4 Bone Marrow Transplants

3.4.1 Graft-versus-Host Disease and Host-versus-Graft Disease

3.4.2 Bone Marrow Transplants and Medicare Coverage

3.4.3 Private Bone Marrow Transplant Forecast 2011-2021

3.4.4 Peripheral Blood Stem Cell Transplants

3.4.5 Cord Blood Stem Cell Transplants

3.5 Stem Cell Services

3.5.1 Disease Modelling

3.5.2 Toxicity Screening

3.5.3 Stem Cell Services Market Forecast 2011-2021

3.6 Blood Banking

3.6.1 Private vs. Public Blood Banks

3.6.2 Arguments For and Against Cord Blood Banking

3.6.3 Private Cord Blood Banking Market Forecast 2011-2021

4. Companies Driving the Stem Cells Market

4.1 Leading Companies Developing Stem Cell Therapies 

4.1.1 Aastrom Biosciences

4.1.2 Advanced Cell Technology

4.1.3 AmStem 

4.1.4 Athersys

4.1.5 BioHeart

4.1.6 BrainStorm Cell Therapeutics

4.1.7 Cytori Therapeutics

4.1.8 Gamida Cell

4.1.9 Geron Geron and GE Healthcare

4.1.10 MediStem Laboratories

4.1.11 Mesoblast

4.1.12 Neostem

4.1.13 Neuralstem

4.1.14 Opexa Therapeutics Tovaxin

4.1.15 Osiris Therapeutics Prochymal Chondrogen

4.1.16 Pluristem Therapeutics

4.1.17 Reliance Life Sciences

4.1.18 ReNeuron

4.1.19 StemCells

4.1.20 TCA Cellular Therapy

4.2 Some Companies Offering Stem Cell Services

4.2.1 Axiogenesis

4.2.2 BioTime CellCure Neurosciences

4.2.3 CellCyte Genetics

4.2.4 Cellular Dynamics International

4.2.5 International Stem Cell Corp

4.2.6 MultiCell Technologies

4.2.7 Regenetech

4.2.8 Stem Cell Innovations

4.2.9 Stemgent

4.2.10 Thermo Fisher Scientific/HyClone

4.2.11 ViaCyte

4.2.12 Vitro Biopharma

4.3 Selected Private Cord Blood Banks

4.3.1 Biogenea-Cellgenea

4.3.2 China Cord Blood Corp

4.3.3 Cord Blood America

4.3.4 Cryo-Cell International

4.3.5 Cryo-Save

4.3.6 LifebankUSA

4.3.7 Thermogenesis

4.3.8 ViaCord

5. Issues Affecting the Stem Cell Technologies Market 2011-2021

5.1 SWOT Chart for the Stem Cells Market 2011-2021

5.2 Strengths

5.2.1 Stem Cell Therapies Already Have a Number of Applications

5.2.2 Stem Cells Have Vast Therapeutic Potential

5.2.3 Stem Cells Have Uses Beyond Therapy

5.2.4 Strength in Numbers

5.2.5 Strong Government Support for Stem Cells

5.3 Weaknesses

5.3.1 The Research Field is Fragmented

5.3.2 A Complex Intellectual Property Environment

5.3.3 Research Relies Too Heavily on Government Funding

5.3.4 Difficulties in Scaling Up

5.3.5 Neither Autologous nor Allogeneic Therapies Are Perfect Yet Autologous Therapies Allogeneic Therapies Incompatibility with the Existing Pharmaceutical Model?

5.4 Opportunities

5.4.1 Leading Pharma Companies Investing in Stem Cell Research

5.4.2 The Potential of iPSCs Transdifferentiation

5.4.3 Philanthropy May Prove a Good Source of Funding

5.4.4 Asia Offers Dynamic Opportunities South Korea Israel

5.4.5 The First New Therapies Launched Will DriveMarket Growth

5.5 Threats

5.5.1 Some Companies Will Fail Case Study: Garnet BioTherapeutics

5.5.2 Maintaining Public Support is Vital but Difficult

5.5.3 Difficulties with Animal Models 

5.5.4 There Remains Uncertainty in the Future Pathway of US Research

5.5.5 Rapid Progress Makes Certain Discoveries Obsolete

6. Therapeutic Applications for Stem Cell Therapies 2011-2021

6.1 Near-Term Indications

6.1.1 Cancer Cancer Stem Cells

6.1.2 Immune Disorders

6.1.3 Eye Diseases

6.1.4 Orthopaedics

6.1.5 Diabetes

6.2 Cardiovascular Diseases

6.3 Central Nervous System (CNS) Diseases

6.3.1 Amyotrophic Lateral Sclerosis (ALS)

6.3.2 Multiple Sclerosis Pelizaeus-Merzbacher Disease (PMD)

6.3.3 Alzheimer's Disease

6.3.4 Cerebral Palsy

6.3.5 Parkinson's Disease

6.3.6 Spinal Cord Injury

6.4 Growing Organs

7. Regional Analysis of the Stem Cells Market 2011-2021

7.1 Global Spread of Stem Cell Research

7.2 The United States

7.2.1 US Market Drivers and Restraints, 2011-2021

7.2.2 California Institute of Regenerative Medicine (CIRM)

7.3 Japan

7.3.1 Commercial Aspects of Stem Cells in Japan

7.4 Europe

7.4.1 The UK

7.4.2 Spain

7.4.3 Germany

7.4.4 France

7.4.5 Italy

7.5 China

7.6 India

8. Research Interview

8.1 Yael Margolin, President and CEO, Gamida Cell

8.1.1 Challenges in Developing Stem Cell Therapies

8.1.2 Israel's Strength in Stem Cell Research

8.1.3 Public Perception of Stem Cell Therapies

8.1.4 Therapeutic Targets and Gamida Cell's Stem Cell Therapies

8.1.5 Umbilical Cord Blood Stem Cells

9. Conclusions

9.1The Stem Cells Market is Currently Small

9.2 Market Growth Will be Dependent on Stem Cell Therapies

9.3 Induced Pluripotent Stem Cells Represent a Strong Market Opportunity

9.4 Stem Cell Therapies Will be Used in Many Disease Areas

9.5 Concluding Remarks

List of Tables

Table 1.1 Currency Exchange Rates, 2009-2010

Table 2.1 Potency and Source of Stem Cells

Table 2.2 Germ Layers and Their Associated Types of Cells and Organs

Table 3.1 Global Stem Cell Market, 2010

Table 3.2 Global Stem Cells Market: Forecast, 2010-2021

Table 3.3 Global Stem Cells Market: Drivers and Restraints, 2011-2021

Table 3.4 Selected Uses for Stem Cells Therapies, 2011

Table 3.5 Stem Cell Therapies Market: Drivers and Restraints, 2011-2021

Table 3.6 Osteocel Plus Sales Forecast, 2010-2021

Table 3.7 Companies Not Considered Part of the Stem Cell Market in this Report

Table 3.8 Sources of Stem Cells for Bone Marrow Transplants

Table 3.9 Medicare Coverage for Bone Marrow Transplants, 2011

Table 3.10 Bone Marrow Transplants Market: Drivers and Restraints, 2011-2021

Table 3.11 Stem Cell Services Market: Drivers and Restraints, 2011-2021

Table 3.12 Costs of Various Private Cord Blood Banks Worldwide, 2011

Table 3.13 Cord Blood Banking Market: Drivers and Restraints, 2011-2021

Table 4.1 Selected Stem Cell Therapy Companies and Their Leading Products, 2011

Table 4.2 Histostem's Leading Clinical Investigations, 2011

Table 4.3 MultiStem Pipeline, 2011

Table 4.4 Gamida Cell's Stem Cell Therapy Pipeline, 2011

Table 4.5 Geron's Stem Cell Therapy Pipeline, 2011

Table 4.6 Clinical Progress of GRN-1632, 2011

Table 4.7 Osiris Therapeutics Stem Cell Pipeline, December 2010

Table 4.8 TCA Cellular Therapy Clinical Progress, 2011

Table 4.9 Selected Stem Cell Services Companies, 2011

Table 4.10 Selected Private Cord Blood Banks, 2011

Table 4.11 China Cord Blood Corp Revenue and Subscribers, 2009-2010

Table 4.12 Cryo-Cell International Revenue, 2009-2010

Table 4.13 Cryo-Save Revenue and Operating Profit, 2009-2010

Table 4.14 Cryo-Save Revenue by Region, 2010

Table 5.1 SWOT Analysis of the Market, 2011-2021 

Table 5.2 NIH Human Stem Cell Research Funding, 2002-2010

Table 6.1 Selected Examples of Stem Cell Research, 2010-2011

Table 6.2 Stem Cell Clinical Trials by Indication, 2011

Table 6.3 Neurodegenerative Diseases: Stem Cell Clinical Trials by Indication, 2011

Table 7.1 Stem Cell Clinical Trials by Country, 2011

Table 7.2 NIH Stem Cell Research Funding, 2002-2010

Table 7.3 CIRM Funding by Disease, 2004-2011

Table 7.4 Indian Stem Cell Clinical Trials Conducted, 2011

Table 9.1 Stem Cells Market Value and Market Shares, 2010, 2016 and 2021

List of Figures

Figure 2.1 The Early History of Stem Cell Discovery and Development

Figure 3.1 Global Stem Cell Market, 2010

Figure 3.2 Global Stem Cells Market Forecast, 2010-2021

Figure 3.3 Stem Cell Therapies Market Forecast, 2010-2021

Figure 3.4 Osteocel Plus Sales Forecast, 2010-2021

Figure 3.5 Private Bone Marrow Transplant Market Forecast, 2011-2021

Figure 3.6 Stem Cell Services Market Forecast, 2010-2021

Figure 3.7 Twenty Year Storage Costs at Various Private Cord Blood Banks Worldwide, 2011

Figure 3.8 Cord Blood Banking Market Forecast, 2010-2021

Figure 4.1 MultiStem Key Events, 2006-2011

Figure 4.2 China Cord Blood Corp Revenue and Subscribers, 2009-2010

Figure 4.3 Cryo-Cell International Revenue, 2009-2010

Figure 4.4 Cryo-Save Revenue and Operating Profit, 2009-2010

Figure 4.5 Cryo-Save Revenue by Region, 2010

Figure 5.1 NIH Human Stem Cell Research Funding, 2002-2010

Figure 5.2 Pfizer's Stem Cell Collaborations, 2008-2011 

Figure 6.1 Stem Cell Clinical Trials for Cancer by Phase, 2011

Figure 6.2 Neurodegenerative Diseases: Stem Cell Clinical Trials by Indication, 2011

Figure 6.3 Five Stages of Parkinson's Disease 

Figure 7.1 Stem Cell Clinical Trials by Country, 2011

Figure 7.2 NIH Stem Cell Research Funding, 2002-2010

Figure 7.3 Key Events in the US Federal Funding of hESC Research Lawsuit, 2009-2010

Figure 7.4 CIRM Funding by Disease, 2004-2011

Figure 7.5 Example of the UK Stem Cell Therapy Regulatory Pathway, 2011

Figure 9.1 Stem Cells Market by Sector, 2016

Figure 9.2 Stem Cells Market by Sector, 2021

Companies Listed

Aastrom Biosciences

Advanced Cell Technology

Agence Nationale de la Recherche [France]



Alliance for Regenerative Medicine


AlphaTec Spine

American Heart Association




AmStem International

Angioblast Systems






AXM Pharma


Beike Biotechnology



BioMimetic Therapeutics


Boston Biomedical

BrainStorm Cell Therapeutics

California Institute of Regenerative Medicine (CIRM)

Care Quality Commission

Catalan Institute for Research and Advanced Studies


Cell Cure Neurosciences


CellCyte Genetics



Cellular Dynamics International



Cha General Hospital [South Korea]

China Cord Blood Corp

Cleveland Clinic

Columbia University

CorCell Companies

Cord Blood America


Cryo-Cell International

Cryo-Cell Mexico


Cytori Therapeutics

Denali Ventures

Department for Health and Human Services [US]

Department of Biotechnology [India]

Department of Defense [US]

Department of Health [UK]

Drugs Controller of India

Duke University Medical Center

Ebryome Sciences (now ReCyte Therapeutics)

EMA Committee for Orphan Medicinal Products

Emerging Healthcare Solutions


ES Cell International

European Court of Justice

European Medicines Agency (EMA)


Fate Therapeutics

FDA Center for Biologics Evaluation and Research [US]

Food and Drug Administration (FDA) [US]

French National Assembly

Gamida Cell

Garnet BioTherapeutics

GE Healthcare

Gene Therapy Advisory Committee [UK]

General BioTechnology


Georgetown University Medical Center



Hadassah Hospital [Israel]

Harvard Stem Cell Institute



Home Office [UK]

Human Fertilisation and Embryology Authority (HFEA) [UK]

Human Tissue Authority (HTA) [UK]



International Consortium of Stem Cell Networks

International Society for Stem Cell Research (ISSCR)

International Stem Cell Corp


iPS Academia Japan

Israel Stem Cell Society

Keele University

Korea Stem Cell Bank

Life R.F.


LifeCell International

Lifeline Cell Technology


Maxim Biotech

Medical College of Georgia

Medical Research Council [UK]

Medicines and Healthcare products Regulatory Agency (MHRA) [UK]

Medipost Co

MediStem Laboratories



Miltenyi Biotec

Ministero della Salute [Italy]

Ministry of Education, Culture, Sports, Science and Technology [Japan]

Ministry of Health [China]

Ministry of Science and Technology [China]

Minneapolis Heart Institute

MultiCell Technologies

Musculoskeletal Transplant Foundation [US]




National Center for Cell Science [India]

National Health Service (NHS) [UK]

National Heart, Lung and Blood Institute [US]

National Institutes of Health (NIH) [US]

National Marrow Donor Program [US]

National Multiple Sclerosis Society [US]



New York Stem Cell Foundation

Nippon Zoki Pharmaceutical

Northwestern University


Novo Nordisk



Oklahoma State House


OncoMed Pharmaceuticals

Opexa Therapeutics




Osiris Therapeutics


Oxford University

Parkinson's UK



Pfizer Regenerative Medicine

Pluristem Therapeutics

Progenitor Cell Therapy


Regenerative Sciences




Reliance Life Sciences


Robert Jones and Agnes Hunt Orthopaedic Hospital


RTI Biologics

Rutgers University

Saneron CCEL Therapeutics



Seoul National University

Spanish Stem Cell Bank

Stanford University


Stem Cell Innovations

Stem Cell Therapeutics




Stempeutics Research Malaysia

SUNY Upstate Medical University

Suzhou Neuralstem Biopharmaceutical Company

TCA Cellular Therapy


Thermo Fisher Scientific



Tissue Bank Cryo Center Bulgaria


UK Stem Cell Bank

University College London (UCL)

University of California

University of Edinburgh

University of Helsinki

University of Kyoto

University of Malaya

University of Massachusetts

University of Michigan

University of Modena Centre for Regenerative Health

University of Pittsburgh

University of Tübingen

University of Wisconsin

US Army Institute of Surgical Research

US Supreme Court

Vaxon Biotech




ViaCyte (formerly Novocell)

Vitro Biopharma

Voss Laboratories

Wake Forest University

Walter and Eliza Institute of Medical Research [Australia]

Weihei Municipal Price Bureau [China]

Wisconsin Alumni Research Foundation (WARF)

XCell Center

Zhejiang Lukou Biotechnology Co

To order this report:

Biological Therapy Industry: Stem Cell Technologies: World Market Outlook 2011-2021

Biological Therapy Business News

More  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Merrimack Announces Presentation of Preclinical Data at the 14th World Conference on Lung Cancer
2. New Jersey Targets Life-Sciences Investors at Worlds Largest Biotechnology Event
3. Most Expensive Teas in the World Worth US$44,500 per 4 Ounces Each are Positioned for International Distribution Says Protein Reactor Combined Fuels Inc (OTC: PRCF) Founder Chairman and CEO Nestor C. Buenaflor
4. Ohios Bioscience Industry Thrives With World-Class Industry Collaboration
5. Reportlinker Adds Orthopedic Biomaterials, The World Market
6. A world without nano? Soon hard to imagine
7. Neurologix Presents One-Year Follow-Up Data From Phase 2 Study of NLX-P101 in Parkinsons Disease at International Neuromodulation Society 10th World Congress
8. Dyadic to Present at the World Congress on Industrial Biotechnology & Bioprocessing
9. ACT Interim Chairman and CEO Gary Rabin to Present at World Stem Cells & Regenerative Medicine Congress in London
10. Verenium to Speak at the 2011 BIO World Congress on Industrial Biotechnology and Bioprocessing
11. Clinical Site Services Expands to Provide Global Patient Enrollment Services to Rest-of-World
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces expanded coverage ... its newest module, US Hemostats & Sealants. , SmartTRAK’s US Market for Hemostats ... sealants, synthetic sealants and biologic sealants used in surgical applications. BioMedGPS estimates the ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Foundation President Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO ... ASTER Labs ), Inc. has been selected for membership in ARCS Alumni ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit ... 7th and 8th June 2018 in San Francisco, CA. The Summit brings together current ... several distinguished CEOs, board directors and government officials from around the world to address ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
Breaking Biology Technology:
(Date:4/13/2017)... , April 13, 2017 According to a new ... Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, ... IAM Market is expected to grow from USD 14.30 Billion in 2017 ... (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/11/2017)... 2017 Research and Markets has announced the ... to their offering. ... eye tracking market to grow at a CAGR of 30.37% during ... Market 2017-2021, has been prepared based on an in-depth market analysis ... and its growth prospects over the coming years. The report also ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
Breaking Biology News(10 mins):